SCHEMBL6672852

SCHEMBL6672852

CCC1CCCC(CC)CCN(CC)CCCC(CC)CC1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.38
HSD11B1 P28845 2/20 0.38
HRH3 Q9Y5N1 2/20 0.37
CHRM5 P08912 1/20 0.35
ADRA2C P18825 1/20 0.35
ACHE P22303 1/20 0.35
EPHX1 P07099 2/20 0.34
CYP2D6 P10635 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2759515 0.96 SMN1; SMN2 (0.41) SMN1; SMN2HSD11B1HRH3CHRM5ADRA2C
SCHEMBL178287 0.87 SMN1; SMN2 (0.46) SMN1; SMN2HSD11B1HRH3ACHEEPHX1
Fluoride SCHEMBL29252276 0.84 SMN1; SMN2 (0.45) SMN1; SMN2HSD11B1HRH3ACHEEPHX1
SCHEMBL26480956 0.83 SMN1; SMN2 (0.41) SMN1; SMN2HSD11B1HRH3EPHX1KMT2A
SCHEMBL23594607 0.81 CHRM5 (0.44) SMN1; SMN2CHRM5ADRA2CACHE
SCHEMBL7075929 0.81 HSD11B1 (0.37) SMN1; SMN2HSD11B1HRH3CHRM5ADRA2C
SCHEMBL12018063 0.81 HSD11B1 (0.37) SMN1; SMN2HSD11B1HRH3CHRM5ADRA2C
Butane SCHEMBL21084740 0.80 SMN1; SMN2 (0.42) SMN1; SMN2HSD11B1HRH3EPHX1EPHX2
Butane SCHEMBL21084742 0.80 SMN1; SMN2 (0.42) SMN1; SMN2HSD11B1HRH3EPHX1EPHX2
SCHEMBL11826729 0.79 SMN1; SMN2 (0.38) SMN1; SMN2HSD11B1HRH3CHRM5ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465611-A2 COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES Murphy, Michael A. (US) 2004-10-13 EP disclosed
WO-2003051348-A2 COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES MURPHY MICHAEL A (US) 2003-06-26 WO disclosed